Primary amebic meningoencephalitis.

dc.contributor.authorRai, Ruchien_US
dc.contributor.authorSingh, D Ken_US
dc.contributor.authorSrivastava, A Ken_US
dc.contributor.authorBhargava, Anuditaen_US
dc.date.accessioned2008-12-09en_US
dc.date.accessioned2009-05-27T04:56:50Z
dc.date.available2008-12-09en_US
dc.date.available2009-05-27T04:56:50Z
dc.date.issued2008-12-09en_US
dc.description.abstractWe report an 8 month-old infant with primary amebic meningoencephalitis (PAME) due to Naegleria fowleri. The child was treated with amphotericin B, chloramphenicol and rifampicin for 3 weeks. PAME is an almost universally fatal condition with very few survivors till date. Our patient was one of the rare survivors who recovered after treatment and was discharged without any residual neurological deficit.en_US
dc.description.affiliationDepartment of Pediatrics, MLN Medical College, University of Allahabad, Allahabad, UP, India. drruchi.rai@indiatimes.comen_US
dc.identifier.citationRai R, Singh DK, Srivastava AK, Bhargava A. Primary amebic meningoencephalitis. Indian Pediatrics. 2008 Dec; 45(12): 1004-5en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/6693
dc.language.isoengen_US
dc.source.urihttps://indianpediatrics.neten_US
dc.subject.meshAmphotericin B --therapeutic useen_US
dc.subject.meshAnimalsen_US
dc.subject.meshAnti-Bacterial Agents --therapeutic useen_US
dc.subject.meshAntibiotics, Antitubercular --therapeutic useen_US
dc.subject.meshChloramphenicol --therapeutic useen_US
dc.subject.meshHumansen_US
dc.subject.meshInfanten_US
dc.subject.meshMaleen_US
dc.subject.meshMeningoencephalitis --diagnosisen_US
dc.subject.meshNaegleria fowleri --isolation & purificationen_US
dc.subject.meshProtein Synthesis Inhibitors --therapeutic useen_US
dc.subject.meshRifampin --therapeutic useen_US
dc.titlePrimary amebic meningoencephalitis.en_US
dc.typeCase Reportsen_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: